Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...

New work by Columbia researchers has turned a textbook principle of genetics on its head and revealed why some people who ...

China's top drug regulator has recently approved the nation's first stem cell therapy to treat a type of complication associated with bone marrow transplant, as well as a novel HIV drug that only ...

A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.

A significant breakthrough in treating the Human Immunodeficiency Virus (HIV) came recently with the US Federal Drug ...

Lenacapavir has shown high efficacy in managing multidrug-resistant cases offering hope to patients with limited alternatives A significant breakthrough in treating the Human Immunodeficiency Virus HI ...